Difference between revisions of "Roche"
Josh Leeson (talk | contribs) |
|||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| + | '''F. Hoffmann–La Roche, Ltd.''' is a Swiss global health-care company which operates world-wide under two divisions: [[Roche Pharma]] and [[Roche Diagnostics]]. It belongs to the '''Roche Holding AG'''. | ||
| + | |||
| + | The headquarters are in Basel and the company has many sites around the world. It owns a majority of the American biotechnology company [[Genentech]] and the Japanese biotechnology company [[Chugai Pharmaceuticals]]. | ||
| + | |||
| + | Descendants of the founding Hoffmann and Oeri families own half of the company. Swiss pharma company [[Novartis]] owns 33% of the company (as of 2005). | ||
| + | |||
| + | ==History== | ||
| + | Founded in 1896 by [[Fritz Hoffmann-La Roche]], the company was early on known for producing various vitamin preparations and derivatives. In 1934, it became the first company to mass produce synthetic vitamin C, under the brand name [[Redoxon]]. In 1957 it introduced the class of tranquilizers known as benzodiazepines (with [[Valium]] and [[Rohypnol]] being the best known members). Its acne drug [[isotretinoin]], marketed as Accutane and Roaccutane, has also been used as a form of chemotherapy for some cancers <ref>[http://www.max001.proboards42.com/index.cgi?board=aa&action=display&thread=1126042049 Roaccutane Science]</ref>, has been linked with a number of very severe side effects and remains highly controversial. Roche has also produced various HIV tests and antiretroviral drugs. It bought the patents for the polymerase chain reaction technique in 1992. It manufactures and sells several cancer] drugs. | ||
| + | |||
| + | In 1976, an accident at a chemical factory in [[Seveso]], Italy owned by a subsidiary of Roche caused a large [[dioxin]] contamination. | ||
| + | |||
| + | In 1982, the United States arm of the company acquired [[Biomedical Reference Laboratories]] for US$163.5 million. That company dated from the late 1960s, and was located in Burlington, North Carolina. That year Hoffmann-La Roche then merged it with all of its laboratories, and incorporated the merged company as [[Roche Biomedical Laboratories]], Inc. in Burlington. By the early 1990s, Roche Biomedical became one of the largest clinical laboratory networks in the United States, with 20 major laboratories and US$600 million in sales.<ref>[http://www.fundinguniverse.com/company-histories/Roche-Biomedical-Laboratories-Inc-Company-History.html Roche Biomedical Laboratories, Inc.], FundingUniverse.com</ref> | ||
| + | |||
| + | On April 28, 1995 Hoffmann-La Roche sold Roche Biomedical Laboratories, Inc. to [[National Health Laboratories Holdings Inc.]], which then changed its name to [[Laboratory Corporation of America Holdings]].<ref>[http://www.secinfo.com/ds2yr.a4.htm Laboratory Corp of America Holdings · 10-Q · For 3/31/95], SECInfo.com, Filed On 5/15/95, SEC File 1-11353, Accession Number 920148-95-11</ref> | ||
| + | In 1994, Roche acquired [[Syntex]]. | ||
| + | |||
| + | == People == | ||
| + | *[[Severin Schwan]] (CEO) | ||
| + | *[[William M. Burns]] (CEO of pharmaceuticals division) | ||
| + | *[[Jonathan Knowles]] (Director of Research) | ||
| + | *Chief Financial Officer Dr [[Erich Hunziker]] (1953) | ||
| + | *Corporate Services and Human Resources Dr [[Gottlieb Keller]] (1954) | ||
| + | ===Corporate Executive Committee=== | ||
| + | |||
| + | *Head Global Pharma Development [[Eduard E. Holdener]] (1945) | ||
| + | *Head Pharma Partnering [[Peter Hug]] (1958) | ||
| + | *Head of Roche Diagnostics' business area Diabetes Care [[Burkhard G. Piper]] (1961) | ||
| + | *Head Global Corporate Communications [[Rolf D. Schläpfer]] (1956) | ||
| + | *Head of Commercial Operations Pharma [[Pascal Soriot]] (1959) | ||
| + | *President and CEO, [[Chugai Osamu Nagayama]] (1947) | ||
| + | |||
==Affiliations== | ==Affiliations== | ||
| − | ==PR and Lobbying companies=== | + | ===PR and Lobbying companies=== |
| + | *[[Incisive Health]]<ref> Incisive Health [http://www.incisivehealth.com/clients Clients], accessed 25 June 2015.</ref> | ||
| + | *[[Deryn]] 2013 - [[Roche]]<ref> [http://www.appc.org.uk/wp-content/uploads/FEB-14-REG-7.3.1411.pdf Register for 1st December 2013 - 28th February 2014] ''APPC'', accessed 24 March 2015 </ref> | ||
*[[Pagoda Public Relations]] - [[Roche Diagnostics Ltd]] | *[[Pagoda Public Relations]] - [[Roche Diagnostics Ltd]] | ||
*[[Grayling]] 2004 -[[Roche UK]], [[Roche]] | *[[Grayling]] 2004 -[[Roche UK]], [[Roche]] | ||
| Line 16: | Line 49: | ||
*[[Manning Selvage and Lee]], 2004 - [[Roche]] | *[[Manning Selvage and Lee]], 2004 - [[Roche]] | ||
*[[Shire Health PR]] 2004 - [[Roche]] | *[[Shire Health PR]] 2004 - [[Roche]] | ||
| − | |||
*[[Chandler Chicco Agency]] | *[[Chandler Chicco Agency]] | ||
| − | |||
*[[AS Biss]] 2005 - [[F Hoffman – La Roche Ltd]] [[Roche Diagnostics Limited]] [[Roche Products Limited]] | *[[AS Biss]] 2005 - [[F Hoffman – La Roche Ltd]] [[Roche Diagnostics Limited]] [[Roche Products Limited]] | ||
| − | |||
*[[Echo Research]] [[Hoffman-La Roche]], | *[[Echo Research]] [[Hoffman-La Roche]], | ||
*[[Business Insights]] - [[Hoffman La Roche]] [[Roche]] | *[[Business Insights]] - [[Hoffman La Roche]] [[Roche]] | ||
| − | *[[Innovex]] | + | *[[Innovex]] 2008, Sales rep provider |
*[[FischerAppelt Kommunikation]] - [[Roche]] Diagnostics [[Roche Diagnostics]] | *[[FischerAppelt Kommunikation]] - [[Roche]] Diagnostics [[Roche Diagnostics]] | ||
*[[Public Affairs Council]] - [[Hoffmann-La Roche Inc.]] | *[[Public Affairs Council]] - [[Hoffmann-La Roche Inc.]] | ||
| + | |||
===Trade Associations, lobby groups and front groups=== | ===Trade Associations, lobby groups and front groups=== | ||
| − | *[[British Nutrition Foundation]] | + | *[[British Nutrition Foundation]] |
*[[European Round Table of Industrialists]] - [[Franz Humer]] - [[F. Hoffmann-La Roche]] | *[[European Round Table of Industrialists]] - [[Franz Humer]] - [[F. Hoffmann-La Roche]] | ||
| − | + | *[[International Federation of Pharmaceutical Manufacturers and Associations]] Dr. [[Franz B. Humer]] of [[F. Hoffmann-La Roche AG]] | |
| − | |||
| − | [[International Federation of Pharmaceutical Manufacturers and Associations]] Dr. [[Franz B. Humer]] of [[F. Hoffmann-La Roche AG]] | ||
*[[Pharmaceutical Research and Manufacturers of America]] - [[Hoffmann-La Roche]] | *[[Pharmaceutical Research and Manufacturers of America]] - [[Hoffmann-La Roche]] | ||
===Patient Groups, NGO's=== | ===Patient Groups, NGO's=== | ||
*[[Rarer Cancers Forum]] [[Roche]] An unrestricted grant | *[[Rarer Cancers Forum]] [[Roche]] An unrestricted grant | ||
| − | *[[National Obesity Forum]] | + | *[[National Obesity Forum]] Orlistat is manufactured by [[Roche Products Ltd]] and [[GlaxoSmithKline UK Ltd]] [[Roche Products Ltd]] were also listed a donor. |
*[[Men's Health Forum]] [[Roche Diagnostics]] £25,000 [[Roche Products]] £91,000 | *[[Men's Health Forum]] [[Roche Diagnostics]] £25,000 [[Roche Products]] £91,000 | ||
*[[International Obesity Taskforce]] [[Roche Pharmaceuticals]] | *[[International Obesity Taskforce]] [[Roche Pharmaceuticals]] | ||
*[[Association for the Study of Obesity]] The main sponsors named in the accounts are: [[Roche]], [[Abbot]] [[Sanofi-Aventis]], [[Unilever]]. | *[[Association for the Study of Obesity]] The main sponsors named in the accounts are: [[Roche]], [[Abbot]] [[Sanofi-Aventis]], [[Unilever]]. | ||
*[[European Men's Health Forum]] - [[Roche]] | *[[European Men's Health Forum]] - [[Roche]] | ||
| + | *[[Cancerbackup]] [[Roche]], the manufacturers of the breast cancer drug Herceptin | ||
| − | + | ==Notes== | |
| + | <references/> | ||
| + | [[category:Pharmaceutical Industry]] | ||
| + | [[Category:Big Pharma]] | ||
Latest revision as of 14:58, 25 June 2015
F. Hoffmann–La Roche, Ltd. is a Swiss global health-care company which operates world-wide under two divisions: Roche Pharma and Roche Diagnostics. It belongs to the Roche Holding AG.
The headquarters are in Basel and the company has many sites around the world. It owns a majority of the American biotechnology company Genentech and the Japanese biotechnology company Chugai Pharmaceuticals.
Descendants of the founding Hoffmann and Oeri families own half of the company. Swiss pharma company Novartis owns 33% of the company (as of 2005).
Contents
History
Founded in 1896 by Fritz Hoffmann-La Roche, the company was early on known for producing various vitamin preparations and derivatives. In 1934, it became the first company to mass produce synthetic vitamin C, under the brand name Redoxon. In 1957 it introduced the class of tranquilizers known as benzodiazepines (with Valium and Rohypnol being the best known members). Its acne drug isotretinoin, marketed as Accutane and Roaccutane, has also been used as a form of chemotherapy for some cancers [1], has been linked with a number of very severe side effects and remains highly controversial. Roche has also produced various HIV tests and antiretroviral drugs. It bought the patents for the polymerase chain reaction technique in 1992. It manufactures and sells several cancer] drugs.
In 1976, an accident at a chemical factory in Seveso, Italy owned by a subsidiary of Roche caused a large dioxin contamination.
In 1982, the United States arm of the company acquired Biomedical Reference Laboratories for US$163.5 million. That company dated from the late 1960s, and was located in Burlington, North Carolina. That year Hoffmann-La Roche then merged it with all of its laboratories, and incorporated the merged company as Roche Biomedical Laboratories, Inc. in Burlington. By the early 1990s, Roche Biomedical became one of the largest clinical laboratory networks in the United States, with 20 major laboratories and US$600 million in sales.[2]
On April 28, 1995 Hoffmann-La Roche sold Roche Biomedical Laboratories, Inc. to National Health Laboratories Holdings Inc., which then changed its name to Laboratory Corporation of America Holdings.[3] In 1994, Roche acquired Syntex.
People
- Severin Schwan (CEO)
- William M. Burns (CEO of pharmaceuticals division)
- Jonathan Knowles (Director of Research)
- Chief Financial Officer Dr Erich Hunziker (1953)
- Corporate Services and Human Resources Dr Gottlieb Keller (1954)
Corporate Executive Committee
- Head Global Pharma Development Eduard E. Holdener (1945)
- Head Pharma Partnering Peter Hug (1958)
- Head of Roche Diagnostics' business area Diabetes Care Burkhard G. Piper (1961)
- Head Global Corporate Communications Rolf D. Schläpfer (1956)
- Head of Commercial Operations Pharma Pascal Soriot (1959)
- President and CEO, Chugai Osamu Nagayama (1947)
Affiliations
PR and Lobbying companies
- Incisive Health[4]
- Deryn 2013 - Roche[5]
- Pagoda Public Relations - Roche Diagnostics Ltd
- Grayling 2004 -Roche UK, Roche
- Grayling Political Strategy, UK Client 2004 Roche
- Hill and Knowlton 2004 Roche
- Edelman UK 2004-05 - Roche Diagnostics
- GPC International UK Client 2004 - Roche Diagnostics
- APCO UK client 2004 Roche Products Ltd
- Fleishman-Hillard UK 2004, 2005 Roche Diagnostics - Europe, Roche Diagnostics
- Ketchum 2004 - Roche Roche Pharma Roche UK
- Burson-Marsteller UK Client, 2004 Roche
- Cohn and Wolfe, 2004 EHoffman-La Roche Roche Consumer Health
- Counsel Public Relations 2004 Roche Roche projects
- Lexis Public Relations 2004 - Roche
- Manning Selvage and Lee, 2004 - Roche
- Shire Health PR 2004 - Roche
- Chandler Chicco Agency
- AS Biss 2005 - F Hoffman – La Roche Ltd Roche Diagnostics Limited Roche Products Limited
- Echo Research Hoffman-La Roche,
- Business Insights - Hoffman La Roche Roche
- Innovex 2008, Sales rep provider
- FischerAppelt Kommunikation - Roche Diagnostics Roche Diagnostics
Trade Associations, lobby groups and front groups
- British Nutrition Foundation
- European Round Table of Industrialists - Franz Humer - F. Hoffmann-La Roche
- International Federation of Pharmaceutical Manufacturers and Associations Dr. Franz B. Humer of F. Hoffmann-La Roche AG
- Pharmaceutical Research and Manufacturers of America - Hoffmann-La Roche
Patient Groups, NGO's
- Rarer Cancers Forum Roche An unrestricted grant
- National Obesity Forum Orlistat is manufactured by Roche Products Ltd and GlaxoSmithKline UK Ltd Roche Products Ltd were also listed a donor.
- Men's Health Forum Roche Diagnostics £25,000 Roche Products £91,000
- International Obesity Taskforce Roche Pharmaceuticals
- Association for the Study of Obesity The main sponsors named in the accounts are: Roche, Abbot Sanofi-Aventis, Unilever.
- European Men's Health Forum - Roche
- Cancerbackup Roche, the manufacturers of the breast cancer drug Herceptin
Notes
- ↑ Roaccutane Science
- ↑ Roche Biomedical Laboratories, Inc., FundingUniverse.com
- ↑ Laboratory Corp of America Holdings · 10-Q · For 3/31/95, SECInfo.com, Filed On 5/15/95, SEC File 1-11353, Accession Number 920148-95-11
- ↑ Incisive Health Clients, accessed 25 June 2015.
- ↑ Register for 1st December 2013 - 28th February 2014 APPC, accessed 24 March 2015
